Patents by Inventor Richard O'Hara
Richard O'Hara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8783873Abstract: Provided is an electronic image display and control system comprising in various embodiments a microdisplay video projector that projects a high quality color image from a non-CRT image source onto a diffused but transmissive optical projection screen that is optically coupled with and viewable through a biocular adapted to this purpose. Systems are disclosed that are adapted to be mechanically coupled with a user to prevent relative movement between the biocular and the user, for instance in tactical applications. Closed-loop control electronics are provided for automatically controlling the brightness and chromaticity of the image.Type: GrantFiled: September 30, 2011Date of Patent: July 22, 2014Assignee: Palomar Display Products, Inc.Inventors: Chris Weinold, Richard O'Hara, Gary L. Timmerman, Jeffrey A. Kovell
-
Patent number: 8526108Abstract: Provided are diffused but transmissive optical image projection screens and methods of their manufacture, including screens comprising acetal polymers such as polyoxymethylene. Such screens may be used in various applications, including but not limited electronic image display and control system comprising in various embodiments a microdisplay video projector that projects a high quality color image from a non-CRT image source onto a diffused but transmissive optical projection screen that is optically coupled with and viewable through a biocular adapted to this purpose. Systems are disclosed that are adapted to be mechanically coupled with a user to prevent relative movement between the biocular and the user, for instance in tactical applications. Closed-loop control electronics are provided for automatically controlling the brightness and chromaticity of the image.Type: GrantFiled: January 12, 2012Date of Patent: September 3, 2013Assignee: Palomar Display Products, Inc.Inventors: Chris Weinold, Richard O'Hara
-
Publication number: 20130089515Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-? or TNF-?. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.Type: ApplicationFiled: July 31, 2012Publication date: April 11, 2013Inventors: John Leonard, Samuel Goldman, Richard O'Hara, JR.
-
Patent number: 8231874Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-? or TNF-?. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.Type: GrantFiled: July 28, 2011Date of Patent: July 31, 2012Inventors: John Leonard, Samuel Goldman, Richard O'Hara, Jr.
-
Publication number: 20120182610Abstract: Provided are diffused but transmissive optical image projection screens and methods of their manufacture, including screens comprising acetal polymers such as polyoxymethylene. Such screens may be used in various applications, including but not limited electronic image display and control system comprising in various embodiments a microdisplay video projector that projects a high quality color image from a non-CRT image source onto a diffused but transmissive optical projection screen that is optically coupled with and viewable through a biocular adapted to this purpose. Systems are disclosed that are adapted to be mechanically coupled with a user to prevent relative movement between the biocular and the user, for instance in tactical applications. Closed-loop control electronics are provided for automatically controlling the brightness and chromaticity of the image.Type: ApplicationFiled: January 12, 2012Publication date: July 19, 2012Applicant: Palomar Display Products, Inc.Inventors: Richard O'Hara, Chris Weinold
-
Publication number: 20120081673Abstract: Provided is an electronic image display and control system comprising in various embodiments a microdisplay video projector that projects a high quality color image from a non-CRT image source onto a diffused but transmissive optical projection screen that is optically coupled with and viewable through a biocular adapted to this purpose. Systems are disclosed that are adapted to be mechanically coupled with a user to prevent relative movement between the biocular and the user, for instance in tactical applications. Closed-loop control electronics are provided for automatically controlling the brightness and chromaticity of the image.Type: ApplicationFiled: September 30, 2011Publication date: April 5, 2012Applicant: Palomar Display Products, Inc.Inventors: Chris Weinold, Richard O'Hara, Gary L. Timmerman, Jeffrey A. Kovell
-
Publication number: 20120020916Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-? or TNF-?. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.Type: ApplicationFiled: July 28, 2011Publication date: January 26, 2012Inventors: John Leonard, Samuel Goldman, Richard O'Hara, JR.
-
Patent number: 8012475Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-? or TNF-?. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.Type: GrantFiled: May 14, 2009Date of Patent: September 6, 2011Assignee: Genetics Institute, LLCInventors: John Leonard, Samuel Goldman, Richard O'Hara, Jr.
-
Publication number: 20090263351Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-? or TNF-?. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.Type: ApplicationFiled: May 14, 2009Publication date: October 22, 2009Inventors: John Leonard, Samuel Goldman, Richard O'Hara, JR.
-
Patent number: 7534430Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-? or TNF-?. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.Type: GrantFiled: September 28, 2006Date of Patent: May 19, 2009Assignee: Genetics Institute, LLCInventors: John Leonard, Samuel Goldman, Richard O'Hara, Jr.
-
Publication number: 20080095774Abstract: The instant invention provides compositions and methods for downmodulation of immune responses, e.g., autoimmune responses. For example, methods of downmodulating an immune response using agents that specifically block CD28-mediated signaling are provided. The subject methods are useful for both prophylactic and therapeutic downmodulation of immune responses.Type: ApplicationFiled: July 31, 2007Publication date: April 24, 2008Applicant: WyethInventors: Richard O'Hara, Ann Nagelin
-
Publication number: 20070162075Abstract: A method and apparatus provides instructions to a user for operating an external defibrillator device having a set of electrodes coupleable to a patient. The method begins by transmitting over a wireless protocol a voice prompt instructing the user to attach the set of electrodes to the patient. The method continues by transmitting over the wireless protocol at least one additional voice prompt instructing the user to administer defibrillator therapy.Type: ApplicationFiled: February 1, 2005Publication date: July 12, 2007Applicant: KONINKLIJKE PHILIPS ELECTRONICS N.V.Inventor: Richard O'Hara
-
Publication number: 20070020233Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-? or TNF-?. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.Type: ApplicationFiled: September 28, 2006Publication date: January 25, 2007Inventors: John Leonard, Samuel Goldman, Richard O'Hara
-
Patent number: 7138115Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-? or TNF-?. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.Type: GrantFiled: September 11, 2003Date of Patent: November 21, 2006Assignee: Genetics Institute, LLCInventors: John P. Leonard, Samuel Goldman, Richard O'Hara, Jr.
-
Publication number: 20060039902Abstract: Methods and compositions for inhibiting interleukin-21 (IL-21)/IL-21 receptor (MU-1) activity using antagonists of IL-21 or IL-21 receptor (“IL-21R” or “MU-1”), are disclosed. IL-21/IL-21R antagonists can be used to induce immune suppression in vivo, e.g., for treating, ameliorating or preventing autoimmune or inflammatory disorders, including, e.g., inflammatory bowel disease (IBD), rheumatoid arthritis (RA), transplant/graft rejection, psoriasis, asthma, fibrosis, and systemic lupus erythematosus (SLE).Type: ApplicationFiled: August 5, 2005Publication date: February 23, 2006Inventors: Deborah Young, Mary Collins, Kyriaki Dunussi-Joannopoulos, Richard O'Hara, Marion Kasaian, Matthew Whitters
-
Publication number: 20050079177Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-? or TNF-?. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.Type: ApplicationFiled: September 11, 2003Publication date: April 14, 2005Applicant: Genetics Institute, LLCInventors: John Leonard, Samuel Goldman, Richard O'Hara
-
Patent number: 6830751Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-&ggr; or TNF-&agr;. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.Type: GrantFiled: February 25, 2000Date of Patent: December 14, 2004Assignee: Genetics Institute, LLCInventors: John Leonard, Samuel Goldman, Richard O'Hara, Jr.
-
Patent number: 6706264Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-&ggr; or TNF-&agr;. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.Type: GrantFiled: February 25, 2000Date of Patent: March 16, 2004Assignee: Genetics Institute, LLCInventors: John Leonard, Samuel Goldman, Richard O'Hara, Jr.
-
Patent number: 6338848Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-&ggr; or TNF-&agr;. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.Type: GrantFiled: February 25, 2000Date of Patent: January 15, 2002Assignee: Genetics Institute, Inc.Inventors: John Leonard, Samuel Goldman, Richard O'Hara, Jr.